FDA.reportPublic FDA data

Aczone 0.075 MG/MG Topical Gel

RxCUI
1741907
RxNorm name
Aczone 0.075 MG/MG Topical Gel
Display name
Aczone 0.075 MG/MG Topical Gel
Full name
Aczone 0.075 MG/MG Topical Gel
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AczoneDAPSONEAlmirall, LLC22058b7d-a578-4eaa-a476-ac982337f02a2025-10-23Warnings, Adverse reactionsExact identifier
rxcui: 1741907

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
22058b7d-a578-4eaa-a476-ac982337f02aAczone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [Aczone] [SBD] · Aczone 0.075 MG/MG Topical Gel [SY] · Aczone 7.5 % Topical Gel [SY]47These highlights do not include all the information needed to use ACZONE ® Gel, 7.5% safely and effectively. See full prescribing information for ACZONE ® Gel, 7.5%. ACZONE ® (dapsone) Gel, 7.5%, for topical use Initial U.S. Approval: 195520251023